表紙:幹細胞製造の中東・アフリカ市場-業界動向と2028年までの予測
市場調査レポート
商品コード
1029959

幹細胞製造の中東・アフリカ市場-業界動向と2028年までの予測

Middle East and Africa Stem Cell Manufacturing Market - Industry Trends and Forecast to 2028

出版日: | 発行: Data Bridge Market Research Private Limited | ページ情報: 英文 110 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
幹細胞製造の中東・アフリカ市場-業界動向と2028年までの予測
出版日: 2021年08月01日
発行: Data Bridge Market Research Private Limited
ページ情報: 英文 110 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中東・アフリカの幹細胞製造市場規模は、2021年から2028年にかけて、10.1%の大幅なCAGRで成長すると予測されています。

当レポートでは、中東・アフリカの幹細胞製造市場について調査分析し、規制、PESTEL分析、ポーターズファイブフォース分析、促進要因、抑制要因、市場機会、課題、COVID-19の影響、製品別、アプリケーション別、エンドユーザー別、流通チャネル別、地域別市場情報、企業情勢、SWOT分析、企業プロファイルを提供しています。

目次

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 中東・アフリカの幹細胞製造市場:規制

  • 規制の枠組み:米国
  • 規制の枠組み:欧州
  • 規制の枠組み:インド
  • 規制の枠組み:日本

第6章 PESTEL分析

第7章 ポーターズファイブフォース分析

第8章 市場概要

  • 促進要因
    • 癌の有病率の増加
    • 研究開発への投資の増加
    • 幹細胞治療の採用の増加
    • ヘルスケア支出の増加によるバイオテクノロジー分野の成長
  • 抑制要因
    • 治療に関連する高コスト
    • 腫瘍治療のための代替利用の可能性
    • 幹細胞移植の副作用
  • 市場機会
    • パイプライン製品の存在
    • 主要プレーヤーによる戦略的イニシアチブ
    • 様々な国でのヘルスケアインフラの増大
    • 個別化医療への関心の高まり
  • 課題
    • 熟練した専門家の不足
    • 厳格な規制

第9章 中東・アフリカの幹細胞製造市場:COVID-19の影響

  • 価格への影響
  • 需要への影響
  • 供給への影響
  • COVID-19間の市場プレーヤーによるイニシアチブ
  • 結論

第10章 中東・アフリカの幹細胞製造市場:製品別

  • 概要
  • 消耗品とキット
    • 培地
    • 差別化キット
    • 幹細胞抗体アレイ
    • 識別キット
    • 幹細胞抗体パネル
    • 幹細胞プライマーペアパネル
    • 造血幹細胞拡張のためのサイトカインパネル
    • 血統枯渇抗体およびキット
    • その他
  • 幹細胞ライン
    • 人細胞システム
    • 齧歯細胞システム
  • 手段
    • バイオリアクターとインキュベーター
    • セルソーター
    • その他

第11章 中東・アフリカの幹細胞製造市場:アプリケーション別

  • 概要
  • 調査アプリケーション
    • ライフサイエンス調査
    • 創薬と開発
  • 臨床アプリケーション
    • 同種幹細胞治療
    • 自家幹細胞治療
  • 細胞と組織のバンキング
  • その他

第12章 中東・アフリカの幹細胞製造市場: エンドユーザー別

  • 概要
  • バイオテクノロジーおよび製薬企業
  • 調査機関および学術機関
  • 細胞バンクと組織バンク
  • 病院および外科センター
  • その他

第13章 中東・アフリカの幹細胞製造市場:流通チャネル別

  • 概要
  • 直接販売
  • 第3者流通

第14章 中東・アフリカの幹細胞製造市場:地域別

第15章 中東・アフリカの幹細胞製造市場:企業情勢

  • 企業シェア分析:中東・アフリカ

第16章 SWOT分析

第17章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • MERCK KGAA
  • AMERICAN CRYOSYSTEM CORPORATION
  • ANTEROGEN.CO.,LTD.
  • ASTELLAS PHARMA INC.
  • BD
  • BIO-TECHNE
  • CATALENT, INC
  • DAIICHI SANKYO COMPANY, LIMITED
  • FUJIFILM CELLULAR DYNAMICS, INC.
  • MESOBLAST LTD
  • ORGANOGENESIS INC.
  • PROMOCELL GMBH
  • REPROCELL INC.
  • SARTORIUS AG
  • STEMCELL TECHNOLOGIES INC.
  • VERICEL CORPORATION
  • VIACYTE, INC.
  • VISTAGEN THERAPEUTICS, INC.

第18章 アンケート

第19章 関連レポート

図表

LIST OF TABLES

TABLE 1 BELOW PROVIDED ARE THE ALTERNATIVES FOR CANCER TREATMENT:

  • TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
  • TABLE 3 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 4 MIDDLE EAST AND AFRICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 5 MIDDLE EAST AND AFRICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 6 MIDDLE EAST AND AFRICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 7 MIDDLE EAST AND AFRICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 8 MIDDLE EAST AND AFRICA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 9 MIDDLE EAST AND AFRICA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 10 MIDDLE EAST AND AFRICA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 11 MIDDLE EAST AND AFRICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 12 MIDDLE EAST AND AFRICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 13 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 14 MIDDLE EAST AND AFRICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 15 MIDDLE EAST AND AFRICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 16 MIDDLE EAST AND AFRICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 17 MIDDLE EAST AND AFRICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 18 MIDDLE EAST AND AFRICA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 19 MIDDLE EAST AND AFRICA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 20 MIDDLE EAST AND AFRICA CELL & TISSUE BANKING IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 21 MIDDLE EAST AND AFRICA OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 22 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 23 MIDDLE EAST AND AFRICA BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 24 MIDDLE EAST AND AFRICA RESEARCH INSTITUTES AND ACADEMIC INSTITUTES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 25 MIDDLE EAST AND AFRICA CELL BANKS & TISSUE BANKS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 26 MIDDLE EAST AND AFRICA HOSPITALS & SURGICAL CENTERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 27 MIDDLE EAST AND AFRICA OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 28 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 29 MIDDLE EAST AND AFRICA DIRECT SALES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 30 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTORS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 31 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 32 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 33 ASIA-PACIFIC CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 34 ASIA-PACIFIC STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 35 ASIA-PACIFIC HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 36 ASIA-PACIFIC PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 37 ASIA-PACIFIC RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 38 ASIA-PACIFIC INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 39 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 40 ASIA-PACIFIC RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 41 ASIA-PACIFIC CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 42 ASIA-PACIFIC ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 43 ASIA-PACIFIC AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 44 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 45 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 46 CHINA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 47 CHINA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 48 CHINA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 49 CHINA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 50 CHINA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 51 CHINA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 52 CHINA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 53 CHINA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 54 CHINA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 55 CHINA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 56 CHINA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 57 CHINA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 58 CHINA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 59 CHINA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 60 JAPAN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 61 JAPAN CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 62 JAPAN STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 63 JAPAN HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 64 JAPAN PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 65 JAPAN RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 66 JAPAN INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 67 JAPAN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 68 JAPAN RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 69 JAPAN CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 70 JAPAN ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 71 JAPAN AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 72 JAPAN STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 73 JAPAN STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 74 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 75 SOUTH KOREA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 76 SOUTH KOREA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 77 SOUTH KOREA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 78 SOUTH KOREA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 79 SOUTH KOREA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 80 SOUTH KOREA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 81 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 82 SOUTH KOREA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 83 SOUTH KOREA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 84 SOUTH KOREA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 85 SOUTH KOREA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 86 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 87 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 88 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 89 AUSTRALIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 90 AUSTRALIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 91 AUSTRALIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 92 AUSTRALIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 93 AUSTRALIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 94 AUSTRALIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 95 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 96 AUSTRALIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 97 AUSTRALIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 98 AUSTRALIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 99 AUSTRALIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 100 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 101 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 102 SINGAPORE STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 103 SINGAPORE CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 104 SINGAPORE STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 105 SINGAPORE HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 106 SINGAPORE PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 107 SINGAPORE RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 108 SINGAPORE INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 109 SINGAPORE STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 110 SINGAPORE RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 111 SINGAPORE CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 112 SINGAPORE ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 113 SINGAPORE AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 114 SINGAPORE STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 115 SINGAPORE STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 116 INDIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 117 INDIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 118 INDIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 119 INDIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 120 INDIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 121 INDIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 122 INDIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 123 INDIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 124 INDIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 125 INDIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 126 INDIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 127 INDIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 128 INDIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 129 INDIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 130 THAILAND STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 131 THAILAND CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 132 THAILAND STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 133 THAILAND HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 134 THAILAND PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 135 THAILAND RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 136 THAILAND INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 137 THAILAND STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 138 THAILAND RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 139 THAILAND CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 140 THAILAND ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 141 THAILAND AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 142 THAILAND STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 143 THAILAND STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 144 MALAYSIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 145 MALAYSIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 146 MALAYSIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 147 MALAYSIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 148 MALAYSIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 149 MALAYSIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 150 MALAYSIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 151 MALAYSIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 152 MALAYSIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 153 MALAYSIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 154 MALAYSIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 155 MALAYSIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 156 MALAYSIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 157 MALAYSIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 158 INDONESIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 159 INDONESIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 160 INDONESIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 161 INDONESIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 162 INDONESIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 163 INDONESIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 164 INDONESIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 165 INDONESIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 166 INDONESIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 167 INDONESIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 168 INDONESIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 169 INDONESIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 170 INDONESIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 171 INDONESIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 172 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 173 PHILIPPINES CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 174 PHILIPPINES STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 175 PHILIPPINES HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 176 PHILIPPINES PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 177 PHILIPPINES RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 178 PHILIPPINES INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 179 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 180 PHILIPPINES RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 181 PHILIPPINES CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 182 PHILIPPINES ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 183 PHILIPPINES AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 184 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 185 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 186 REST OF ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: SEGMENTATION
  • FIGURE 2 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: DATA TRIANGULATION
  • FIGURE 3 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: DROC ANALYSIS
  • FIGURE 4 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET : MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET : COMPANY RESEARCH ANALYSIS
  • FIGURE 6 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 9 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 10 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: SEGMENTATION
  • FIGURE 11 INCREASING ADOPTION OF STEM CELL THERAPY IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 12 CONSUMABLES & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET IN 2021 & 2028
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET
  • FIGURE 14 NEW CANCER CASES WORLDWIDE IN 2018
  • FIGURE 15 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2020
  • FIGURE 16 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, 2021-2028 (USD MILLION )
  • FIGURE 17 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, CAGR (2021-2028)
  • FIGURE 18 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, LIFELINE CURVE
  • FIGURE 19 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2020
  • FIGURE 20 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, 2021-2028 (USD MILLION )
  • FIGURE 21 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, CAGR (2021-2028)
  • FIGURE 22 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 23 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY END USER, 2020
  • FIGURE 24 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY END USER, 2021-2028 (USD MILLION )
  • FIGURE 25 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY END USER, CAGR (2021-2028)
  • FIGURE 26 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 27 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2020
  • FIGURE 28 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION )
  • FIGURE 29 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
  • FIGURE 30 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 31 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: SNAPSHOT (2020)
  • FIGURE 32 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020)
  • FIGURE 33 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 34 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 35 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS (2021-2028)
  • FIGURE 36 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: COMPANY SHARE 2020 (%)
目次

Middle East and Africa stem cell manufacturing market is projected to register a substantial CAGR of 10.1% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020, and the forecast period is 2021 to 2028.

Market Segmentation:

Middle East and Africa Stem Cell Manufacturing Market, By Products (Stem Cell Lines, Instruments, Consumables & Kits), Application (Research Applications, Clinical Applications, Cell and Tissue Banking and Others),End User (Biotechnology & Pharmaceutical Companies, Research Institutes and Academic Institutes, Cell Banks and Tissue Banks, Hospital & Surgical Centers and Others), Distribution Channel (Direct Sales and Third Party Distributor), Country (South Africa, Saudi Arabia, UAE, Israel, Egypt & Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of the Middle East and Africa stem cell manufacturing market are:

  • Growing adoption of stem cell transplant
  • Strategic Initiatives by key players
  • Large number of pipeline products

Market Players:

The key market players for Middle East and Africa stem cell manufacturing market are listed below:

  • Thermo Fisher Scientific Inc.,
  • Merck KGaA,
  • BD,
  • Sartorius AG,
  • STEM CELL Technologies, Inc.,
  • Takeda Pharmaceutical Company Limited,
  • DAIICHI SANKYO COMPANY, LIMITED,
  • Bio-Techne,
  • REPROCELL Inc.,
  • Catalent, Inc,
  • Mesoblast Ltd
  • Astellas Pharma Inc.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCTS LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: REGULATIONS

  • 5.1 REGULATORY FRAMEWORK IN THE UNITED STATES
  • 5.2 REGULATORY FRAMEWORK IN EUROPE
  • 5.3 REGULATORY FRAMEWORK IN INDIA
  • 5.4 REGULATORY FRAMEWORK IN JAPAN

6 PESTEL ANALYSIS

7 PORTERS FIVE FORCES

8 MARKET OVERVIEW

  • 8.1 DRIVERS
    • 8.1.1 INCREASING PREVALENCE OF CANCER
    • 8.1.2 INCREASE INVESTMENT IN R & D
    • 8.1.3 INCREASING ADOPTION OF STEM CELL THERAPY
    • 8.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
  • 8.2 RESTRAINTS
    • 8.2.1 HIGH COST ASSOCIATED WITH THERAPIES
    • 8.2.2 AVAILABILITY OF ALTERNATIVES FOR TUMOR TREATMENT
    • 8.2.3 ADVERSE EFFECTS OF STEM CELL TRANSPLANT
  • 8.3 OPPORTUNITIES
    • 8.3.1 PRESENCE OF PIPELINE PRODUCTS
    • 8.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
    • 8.3.3 RISING HEALTHCARE INFRASTRUCTURE BY VARIOUS COUNTRIES
    • 8.3.4 INCREASING INTEREST FOR PERSONALIZED MEDICINE
  • 8.4 CHALLENGES
    • 8.4.1 LACK OF SKILLED PROFESSIONALS
    • 8.4.2 STRINGENT REGULATIONS

9 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET

  • 9.1 IMPACT ON PRICE
  • 9.2 IMPACT ON DEMAND
  • 9.3 IMPACT ON SUPPLY
  • 9.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID-19
  • 9.5 CONCLUSION

10 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS

  • 10.1 OVERVIEW
  • 10.2 CONSUMABLES & KITS
    • 10.2.1 CULTURE MEDIA
    • 10.2.2 DIFFERENTIATION KITS
    • 10.2.3 STEM CELL ANTIBODY ARRAYS
    • 10.2.4 IDENTIFICATION KITS
    • 10.2.5 STEM CELL ANTIBODY PANELS
    • 10.2.6 STEM CELL PRIMER PAIR PANELS
    • 10.2.7 CYTOKINE PANELS FOR HEMATOPOIETIC STEM CELL EXPANSION
    • 10.2.8 LINEAGE DEPLETION ANTIBODIES & KITS
    • 10.2.9 OTHERS
  • 10.3 STEM CELL LINES
    • 10.3.1 HUMAN CELL SYSTEMS
      • 10.3.1.1 INDUCED PLURIPOTENT EMBRYONIC STEM CELLS
      • 10.3.1.2 MESENCHYMAL STEM CELLS
      • 10.3.1.3 PRIMARY HUMAN CELLS
        • 10.3.1.3.1 FIBROBLAST
        • 10.3.1.3.2 EPITHELIAL
        • 10.3.1.3.3 ENDOTHELIAL
      • 10.3.1.4 HEMATOPOIETIC STEM CELLS
      • 10.3.1.5 NEURAL STEM CELLS
      • 10.3.1.6 CARDIAC STEM CELLS
      • 10.3.1.7 PANCREATIC STEM CELLS
      • 10.3.1.8 OTHERS
    • 10.3.2 RODENT CELL SYSTEMS
      • 10.3.2.1 PLURIPOTENT MOUSE ES CELLS
      • 10.3.2.2 MOUSE EMBRYO CULTURE
      • 10.3.2.3 PMEFS
      • 10.3.2.4 MULTIPOTENT RODENT STEM CELLS
      • 10.3.2.5 MESENCHYMAL STEM CELLS
      • 10.3.2.6 NEURAL STEM CELLS
      • 10.3.2.7 OTHERS
  • 10.4 INSTRUMENTS
    • 10.4.1 BIOREACTORS & INCUBATORS
    • 10.4.2 CELL SORTERS
    • 10.4.3 OTHERS

11 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY APPLICATION

  • 11.1 OVERVIEW
  • 11.2 RESEARCH APPLICATIONS
    • 11.2.1 LIFE SCIENCE RESEARCH
    • 11.2.2 DRUG DISCOVERY AND DEVELOPMENT
  • 11.3 CLINICAL APPLICATIONS
    • 11.3.1 ALLOGENIC STEM CELL THERAPY
      • 11.3.1.1 SURGERIES
      • 11.3.1.2 MUSCULOSKELETAL DISORDERS
      • 11.3.1.3 WOUNDS AND INJURIES
      • 11.3.1.4 ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
      • 11.3.1.5 OTHERS
    • 11.3.2 AUTOLOGOUS STEM CELL THERAPY
      • 11.3.2.1 WOUNDS & INJURIES
      • 11.3.2.2 CARDIOVASCULAR DISEASES
      • 11.3.2.3 GASTROINTESTINAL DISEASES
      • 11.3.2.4 OTHERS
  • 11.4 CELL & TISSUE BANKING
  • 11.5 OTHERS

12 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY END USER

  • 12.1 OVERVIEW
  • 12.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 12.3 RESEARCH INSTITUTES AND ACADEMIC INSTITUTES
  • 12.4 CELL BANKS & TISSUE BANKS
  • 12.5 HOSPITALS & SURGICAL CENTERS
  • 12.6 OTHERS

13 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL

  • 13.1 OVERVIEW
  • 13.2 DIRECT SALES
  • 13.3 THIRD PARTY DISTRIBUTORS

14 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET, BY REGION

  • 14.1 ASIA-PACIFIC
    • 14.1.1 CHINA
    • 14.1.2 JAPAN
    • 14.1.3 SOUTH KOREA
    • 14.1.4 AUSTRALIA
    • 14.1.5 SINGAPORE
    • 14.1.6 INDIA
    • 14.1.7 THAILAND
    • 14.1.8 MALAYSIA
    • 14.1.9 INDONESIA
    • 14.1.10 PHILIPPINES
    • 14.1.11 REST OF ASIA-PACIFIC

15 MIDDLE EAST AND AFRICA STEM CELL MANUFACTURING MARKET: COMPANY LANDSCAPE

  • 15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

16 SWOT ANALYSIS

17 COMPANY PROFILE

  • 17.1 THERMO FISHER SCIENTIFIC INC.
    • 17.1.1 COMPANY SNAPSHOT
    • 17.1.2 REVENUE ANALYSIS
    • 17.1.3 COMPANY SHARE ANALYSIS
    • 17.1.4 PRODUCT PORTFOLIO
    • 17.1.5 RECENT DEVELOPMENT
  • 17.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
    • 17.2.1 COMPANY SNAPSHOT
    • 17.2.2 REVENUE ANALYSIS
    • 17.2.3 COMPANY SHARE ANALYSIS
    • 17.2.4 PRODUCT PORTFOLIO
    • 17.2.5 RECENT DEVELOPMENTS
  • 17.3 MERCK KGAA
    • 17.3.1 COMPANY SNAPSHOT
    • 17.3.2 REVENUE ANALYSIS
    • 17.3.3 COMPANY SHARE ANALYSIS
    • 17.3.4 PRODUCT PORTFOLIO
    • 17.3.5 RECENT DEVELOPMENTS
  • 17.4 AMERICAN CRYOSYSTEM CORPORATION
    • 17.4.1 COMPANY SNAPSHOT
    • 17.4.2 REVENUE ANALYSIS
    • 17.4.3 PRODUCT PORTFOLIO
    • 17.4.4 RECENT DEVELOPMENTS
  • 17.5 ANTEROGEN.CO.,LTD.
    • 17.5.1 COMPANY SNAPSHOT
    • 17.5.2 REVENUE ANALYSIS
    • 17.5.3 PRODUCT PORTFOLIO
    • 17.5.4 RECENT DEVELOPMENT
  • 17.6 ASTELLAS PHARMA INC.
    • 17.6.1 COMPANY SNAPSHOT
    • 17.6.2 REVENUE ANALYSIS
    • 17.6.3 PRODUCT PORTFOLIO
    • 17.6.4 RECENT DEVELOPMENT
  • 17.7 BD
    • 17.7.1 COMPANY SNAPSHOT
    • 17.7.2 REVENUE ANALYSIS
    • 17.7.3 COMPANY SHARE ANALYSIS
    • 17.7.4 PRODUCT PORTFOLIO
    • 17.7.5 RECENT DEVELOPMENT
  • 17.8 BIO-TECHNE
    • 17.8.1 COMPANY SNAPSHOT
    • 17.8.2 REVENUE ANALYSIS
    • 17.8.3 PRODUCT PORTFOLIO
    • 17.8.4 RECENT DEVELOPMENTS
  • 17.9 CATALENT, INC
    • 17.9.1 COMPANY SNAPSHOT
    • 17.9.2 REVENUE ANALYSIS
    • 17.9.3 PRODUCT PORTFOLIO
    • 17.9.4 RECENT DEVELOPMENTS
  • 17.10 DAIICHI SANKYO COMPANY, LIMITED
    • 17.10.1 COMPANY SNAPSHOT
    • 17.10.2 REVENUE ANALYSIS
    • 17.10.3 PRODUCT PORTFOLIO
    • 17.10.4 RECENT DEVELOPMENT
  • 17.11 FUJIFILM CELLULAR DYNAMICS, INC.
    • 17.11.1 COMPANY SNAPSHOT
    • 17.11.2 COMPANY SHARE ANALYSIS
    • 17.11.3 PRODUCT PORTFOLIO
    • 17.11.4 RECENT DEVELOPMENTS
  • 17.12 MESOBLAST LTD
    • 17.12.1 COMPANY SNAPSHOT
    • 17.12.2 REVENUE ANALYSIS
    • 17.12.3 PRODUCT PORTFOLIO
    • 17.12.4 RECENT DEVELOPMENT
  • 17.13 ORGANOGENESIS INC.
    • 17.13.1 COMPANY SNAPSHOT
    • 17.13.2 PRODUCT PORTFOLIO
    • 17.13.3 RECENT DEVELOPMENT
  • 17.14 PROMOCELL GMBH
    • 17.14.1 COMPANY SNAPSHOT
    • 17.14.2 PRODUCT PORTFOLIO
    • 17.14.3 RECENT DEVELOPMENTS
  • 17.15 REPROCELL INC.
    • 17.15.1 COMPANY SNAPSHOT
    • 17.15.2 REVENUE ANALYSIS
    • 17.15.3 PRODUCT PORTFOLIO
    • 17.15.4 RECENT DEVELOPMENTS
  • 17.16 SARTORIUS AG
    • 17.16.1 COMPANY SNAPSHOT
    • 17.16.2 REVENUE ANALYSIS
    • 17.16.3 PRODUCT PORTFOLIO
    • 17.16.4 RECENT DEVELOPMENTS
  • 17.17 STEMCELL TECHNOLOGIES INC.
    • 17.17.1 COMPANY SNAPSHOT
    • 17.17.2 PRODUCT PORTFOLIO
    • 17.17.3 RECENT DEVELOPMENTS
  • 17.18 VERICEL CORPORATION
    • 17.18.1 COMPANY SNAPSHOT
    • 17.18.2 REVENUE ANALYSIS
    • 17.18.3 PRODUCT PORTFOLIO
    • 17.18.4 RECENT DEVELOPMENTS
  • 17.19 VIACYTE, INC.
    • 17.19.1 COMPANY SNAPSHOT
    • 17.19.2 PRODUCT PORTFOLIO
    • 17.19.3 RECENT DEVELOPMENTS
  • 17.20 VISTAGEN THERAPEUTICS, INC.
    • 17.20.1 COMPANY SNAPSHOT
    • 17.20.2 PRODUCT PORTFOLIO
    • 17.20.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS